Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
03 April 2019 | Story Xolisa Mnukwa | Photo Vhugala Nthakheni
Uhuru Qwaqwa Arrival
The #UFSWalkToUhuru team arrives at the UFS Qwaqwa Campus on Friday 22 March.

The University of the Free State (UFS) Division of Student Affairs, in collaboration with the UFS Office for International Affairs, have joined hands to drive a fundraising and student-accessibility initiative dubbed, ‘The Walk to Uhuru’ (#UFSWalktoUhuru), which is aimed at raising funds and advocating for the educational rights of the less privileged. 

The project aims to raise funds in excess of R2 million from the public and stakeholders affiliated with the UFS (Kovsie staff and students). The project derives from the 2018/2019 UFS Institutional Student Representative Council (ISRC) mandate ‘Students Must Graduate’. The ISRC mandate aims to source funding opportunities for UFS students to register, and to complete their studies across all three campuses in 2020 and beyond.

The first leg of the project, a 350 km walk from the Bloemfontein to the Qwaqwa Campus, has already taken place and concluded on Friday, 22 March 2019 as planned. The #UFSWalkToUhuru team successfully completed the first leg of their journey to academic freedom for financially disadvantaged students at the UFS. The Uhuru team is now focusing its attention on the second leg and is determined to take on Mount Kilimanjaro (Uhuru) from 20 June to 20 July 2019.

The team sat down for a debriefing session to unpack the overall experience and result of the first half of the initiative, and they all agreed that the walk to Qwaqwa was an enlightening experience. It was a walk that comprised learning opportunities, team building, and goal crushing.

According to Rethabile Motseki, member of the #UFSWalkToUhuru team, the walk to Qwaqwa made a significant impact on the project, as the university community is now aware of the significant goals that the team is trying to accomplish. The team has also resumed their fitness-training programme to ensure that they are ready to take on the Uhuru climb in June.

A media briefing will take place shortly (date to be confirmed) to detail the ongoing fundraising initiatives rolled out by the #UFSWalkToUhuru team.  We implore you, and the nation as a whole, to help establish a better future for disadvantaged UFS students by donating to the initiative.

Students, staff, and the public can support the cause and make contributions/donations to the initiative by visiting the UFS Walk to Uhuru #givengain account page.

For more information, contact UFS SRC President, Sonwabile Dwaba, on DwabaSJ@ufs.ac.za  or Rethabile Motseki on MotsekiR@ufs.ac.za  

Dr Martin Mandew, Qwaqwa Campus Principal
Dr Martin Mandew, Qwaqwa Campus Principal
#UFSWalktoUhuru arrives the Qwaqwa Campus
#UFSWalktoUhuru arrives the Qwaqwa Campus
Final day of #UFSWalktoUhuru 4
Final day of #UFSWalktoUhuru 4
Final day of #UFSWalktoUhuru 3
Final day of #UFSWalktoUhuru 3
Final day of #UFSWalktoUhuru 2
Final day of #UFSWalktoUhuru 2
Final day of #UFSWalktoUhuru
Final day of #UFSWalktoUhuru
#WalkToUhuru 10
#WalkToUhuru 10
#WalkToUhuru 9
#WalkToUhuru 9
#WalkToUhuru 8
#WalkToUhuru 8
#WalkToUhuru 7
#WalkToUhuru 7
#WalkToUhuru 6
#WalkToUhuru 6
#WalkToUhuru 5
#WalkToUhuru 5
#WalkToUhuru 4
#WalkToUhuru 4
#WalkToUhuru 3
#WalkToUhuru 3
#WalkToUhuru 2
#WalkToUhuru 2
#WalkToUhuru 1
#WalkToUhuru 1

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept